Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.
Identifieur interne : 003D48 ( Main/Curation ); précédent : 003D47; suivant : 003D49Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.
Auteurs : Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane ; Shigeru MorikawaSource :
- FEBS letters [ 0014-5793 ] ; 2006.
Descripteurs français
- KwdFr :
- Animaux, Cellules Vero, Facteur de croissance épidermique (pharmacologie), Phosphorylation, Ribosomal Protein S6 Kinases, 90-kDa (métabolisme), Syndrome respiratoire aigu sévère (métabolisme), Sérine (métabolisme), Thréonine (métabolisme), Transduction du signal, Virus du SRAS, p38 Mitogen-Activated Protein Kinases (métabolisme).
- MESH :
English descriptors
- KwdEn :
- Animals, Chlorocebus aethiops, Epidermal Growth Factor (pharmacology), Phosphorylation, Ribosomal Protein S6 Kinases, 90-kDa (metabolism), SARS Virus, Serine (metabolism), Severe Acute Respiratory Syndrome (metabolism), Signal Transduction, Threonine (metabolism), Vero Cells, p38 Mitogen-Activated Protein Kinases (metabolism).
- MESH :
- chemical , metabolism : Ribosomal Protein S6 Kinases, 90-kDa, Serine, Threonine, p38 Mitogen-Activated Protein Kinases.
- chemical , pharmacology : Epidermal Growth Factor.
- metabolism : Severe Acute Respiratory Syndrome.
- Animals, Chlorocebus aethiops, Phosphorylation, SARS Virus, Signal Transduction, Vero Cells.
Abstract
The 90 kDa ribosomal S6 kinases (p90RSKs) are a family of broadly expressed serine/threonine kinases with two kinase domains activated by extracellular signal-regulated protein kinase in response to many growth factors. Our recent study demonstrated that severe acute respiratory syndrome (SARS)-coronavirus (CoV) infection of monkey kidney Vero E6 cells induces phosphorylation and dephosphorylation of signaling pathways, resulting in apoptosis. In the present study, we investigated the phosphorylation status of p90RSK, which is a well-known substrate of these signaling pathways, in SARS-CoV-infected cells. Vero E6 mainly expressed p90RSK1 and showed weak expression of p90RSK2. In the absence of viral infection, Ser221 in the N-terminal kinase domain was phosphorylated constitutively, whereas both Thr573 in the C-terminal kinase domain and Ser380 between the two kinase domains were not phosphorylated in confluent cells. Ser380, which has been reported to be involved in autophosphorylation by activation of the C-terminal kinase domain, was phosphorylated in confluent SARS-CoV-infected cells, and this phosphorylation was inhibited by , which is an inhibitor of p38 mitogen-activated protein kinases (MAPK). Phosphorylation of Thr573 was not upregulated in SARS-CoV-infected cells. Thus, in virus-infected cells, phosphorylation of Thr573 was not necessary to induce phosphorylation of Ser380. On the other hand, Both Thr573 and Ser380 were phosphorylated by treatment with epidermal growth factor (EGF) in the absence of p38 MAPK activation. Ser220 was constitutively phosphorylated despite infection. These results indicated that phosphorylation status of p90RSK by SARS-CoV infection is different from that by stimulation of EGF. This is the first detailed report regarding regulation of p90RSK phosphorylation by virus infection.
DOI: 10.1016/j.febslet.2006.01.066
PubMed: 16458888
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002355
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002355
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002037
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001365
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001365
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001365
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003F21
Links to Exploration step
pubmed:16458888Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.</title>
<author><name sortKey="Mizutani, Tetsuya" sort="Mizutani, Tetsuya" uniqKey="Mizutani T" first="Tetsuya" last="Mizutani">Tetsuya Mizutani</name>
<affiliation wicri:level="1"><nlm:affiliation>Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011, Japan. tmizutan@nih.go.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fukushi, Shuetsu" sort="Fukushi, Shuetsu" uniqKey="Fukushi S" first="Shuetsu" last="Fukushi">Shuetsu Fukushi</name>
</author>
<author><name sortKey="Saijo, Masayuki" sort="Saijo, Masayuki" uniqKey="Saijo M" first="Masayuki" last="Saijo">Masayuki Saijo</name>
</author>
<author><name sortKey="Kurane, Ichiro" sort="Kurane, Ichiro" uniqKey="Kurane I" first="Ichiro" last="Kurane">Ichiro Kurane</name>
</author>
<author><name sortKey="Morikawa, Shigeru" sort="Morikawa, Shigeru" uniqKey="Morikawa S" first="Shigeru" last="Morikawa">Shigeru Morikawa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16458888</idno>
<idno type="pmid">16458888</idno>
<idno type="doi">10.1016/j.febslet.2006.01.066</idno>
<idno type="wicri:Area/PubMed/Corpus">002355</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002355</idno>
<idno type="wicri:Area/PubMed/Curation">002355</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002355</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002037</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002037</idno>
<idno type="wicri:Area/Ncbi/Merge">001365</idno>
<idno type="wicri:Area/Ncbi/Curation">001365</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001365</idno>
<idno type="wicri:doubleKey">0014-5793:2006:Mizutani T:regulation:of:p</idno>
<idno type="wicri:Area/Main/Merge">003F21</idno>
<idno type="wicri:Area/Main/Curation">003D48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.</title>
<author><name sortKey="Mizutani, Tetsuya" sort="Mizutani, Tetsuya" uniqKey="Mizutani T" first="Tetsuya" last="Mizutani">Tetsuya Mizutani</name>
<affiliation wicri:level="1"><nlm:affiliation>Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011, Japan. tmizutan@nih.go.jp</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fukushi, Shuetsu" sort="Fukushi, Shuetsu" uniqKey="Fukushi S" first="Shuetsu" last="Fukushi">Shuetsu Fukushi</name>
</author>
<author><name sortKey="Saijo, Masayuki" sort="Saijo, Masayuki" uniqKey="Saijo M" first="Masayuki" last="Saijo">Masayuki Saijo</name>
</author>
<author><name sortKey="Kurane, Ichiro" sort="Kurane, Ichiro" uniqKey="Kurane I" first="Ichiro" last="Kurane">Ichiro Kurane</name>
</author>
<author><name sortKey="Morikawa, Shigeru" sort="Morikawa, Shigeru" uniqKey="Morikawa S" first="Shigeru" last="Morikawa">Shigeru Morikawa</name>
</author>
</analytic>
<series><title level="j">FEBS letters</title>
<idno type="ISSN">0014-5793</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Epidermal Growth Factor (pharmacology)</term>
<term>Phosphorylation</term>
<term>Ribosomal Protein S6 Kinases, 90-kDa (metabolism)</term>
<term>SARS Virus</term>
<term>Serine (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (metabolism)</term>
<term>Signal Transduction</term>
<term>Threonine (metabolism)</term>
<term>Vero Cells</term>
<term>p38 Mitogen-Activated Protein Kinases (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Facteur de croissance épidermique (pharmacologie)</term>
<term>Phosphorylation</term>
<term>Ribosomal Protein S6 Kinases, 90-kDa (métabolisme)</term>
<term>Syndrome respiratoire aigu sévère (métabolisme)</term>
<term>Sérine (métabolisme)</term>
<term>Thréonine (métabolisme)</term>
<term>Transduction du signal</term>
<term>Virus du SRAS</term>
<term>p38 Mitogen-Activated Protein Kinases (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Ribosomal Protein S6 Kinases, 90-kDa</term>
<term>Serine</term>
<term>Threonine</term>
<term>p38 Mitogen-Activated Protein Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Epidermal Growth Factor</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Ribosomal Protein S6 Kinases, 90-kDa</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Sérine</term>
<term>Thréonine</term>
<term>p38 Mitogen-Activated Protein Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Facteur de croissance épidermique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Phosphorylation</term>
<term>SARS Virus</term>
<term>Signal Transduction</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Cellules Vero</term>
<term>Phosphorylation</term>
<term>Transduction du signal</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The 90 kDa ribosomal S6 kinases (p90RSKs) are a family of broadly expressed serine/threonine kinases with two kinase domains activated by extracellular signal-regulated protein kinase in response to many growth factors. Our recent study demonstrated that severe acute respiratory syndrome (SARS)-coronavirus (CoV) infection of monkey kidney Vero E6 cells induces phosphorylation and dephosphorylation of signaling pathways, resulting in apoptosis. In the present study, we investigated the phosphorylation status of p90RSK, which is a well-known substrate of these signaling pathways, in SARS-CoV-infected cells. Vero E6 mainly expressed p90RSK1 and showed weak expression of p90RSK2. In the absence of viral infection, Ser221 in the N-terminal kinase domain was phosphorylated constitutively, whereas both Thr573 in the C-terminal kinase domain and Ser380 between the two kinase domains were not phosphorylated in confluent cells. Ser380, which has been reported to be involved in autophosphorylation by activation of the C-terminal kinase domain, was phosphorylated in confluent SARS-CoV-infected cells, and this phosphorylation was inhibited by , which is an inhibitor of p38 mitogen-activated protein kinases (MAPK). Phosphorylation of Thr573 was not upregulated in SARS-CoV-infected cells. Thus, in virus-infected cells, phosphorylation of Thr573 was not necessary to induce phosphorylation of Ser380. On the other hand, Both Thr573 and Ser380 were phosphorylated by treatment with epidermal growth factor (EGF) in the absence of p38 MAPK activation. Ser220 was constitutively phosphorylated despite infection. These results indicated that phosphorylation status of p90RSK by SARS-CoV infection is different from that by stimulation of EGF. This is the first detailed report regarding regulation of p90RSK phosphorylation by virus infection.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003D48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:16458888 |texte= Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:16458888" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |